Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991 Apr;65(4):1985-90.
doi: 10.1128/JVI.65.4.1985-1990.1991.

Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo

Affiliations
Comparative Study

Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo

B R Davis et al. J Virol. 1991 Apr.

Abstract

An important question in human immunodeficiency virus (HIV) pathogenesis is whether HIV-infected bone marrow CD34+ stem/progenitor cells serve as a significant reservoir of virus in HIV-infected individuals. Our data indicate that infection of bone marrow stem/progenitor cells with HIV occurs rarely, if ever, in vivo. In the present study, CD34+ cells were immunomagnetically purified from the bone marrow of HIV-seropositive individuals, and purified cells or colony-forming cells of the granulocyte/macrophage lineage were analyzed for HIV proviral DNA by the polymerase chain reaction. No HIV DNA was detected in colony-forming cells of the granulocyte/macrophage lineage from HIV-positive patients. Furthermore, no virus was found in CD34(+)-enriched cells from six of seven samples from asymptomatic HIV-infected individuals and four of four samples from patients with AIDS-related complex or AIDS. Thus, infected stem cells are not a major source of persistent HIV and do not account for hematopoietic suppression. These findings have positive implications for the concept of marrow reconstitution with autologous stem cells, genetically engineered for HIV resistance, following marrow-ablative antiviral therapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1984 Jul;133(1):157-65 - PubMed
    1. Blood. 1990 Dec 15;76(12):2476-82 - PubMed
    1. Blood. 1986 Mar;67(3):842-5 - PubMed
    1. J Exp Med. 1986 Jul 1;164(1):280-90 - PubMed
    1. Science. 1986 Sep 5;233(4768):1076-8 - PubMed

Publication types